17 August 2020 - AstraZeneca has finalised an agreement with the European Commission to supply up to 400 million doses of its AZD1222 COVID-19 vaccine.

Building on the existing agreement with Europe’s Inclusive Vaccines Alliance spearheaded by Germany, France, Italy and the Netherlands, this deal will give all EU member states the option to access the vaccine “in an equitable manner at no profit during the pandemic,” the company said.

It also enables EU member states to redirect doses to other European countries, as needed.

Read Pharma Times article